Sign in

Mondelez International, Inc. (MDLZ) Q3 2025 Earnings Summary

Executive Summary

  • Q3 2025 delivered modest top-line growth with material gross margin and EBIT compression from record cocoa cost inflation; net revenues rose to $9.74B (+5.9% YoY) while GAAP EPS fell to $0.57 and Adjusted EPS to $0.73 .
  • Versus Wall Street, MDLZ posted an EPS beat (+3% vs consensus $0.709*) and a slight revenue beat (+0.7% vs $9.67B*), but a notable EBITDA miss (~-13% vs $1.61B*), reflecting input cost pressure and unfavorable mix .
  • Management lowered full-year guidance: Organic Net Revenue growth to “4%+” (from ~5%) and Adjusted EPS decline to ~15% (from ~10%) on constant FX; FCF outlook maintained at $3B+, with currency now a ~0.5% tailwind to revenue and +$0.05 to Adjusted EPS .
  • Key call themes: European chocolate price elasticities higher than planned (0.7–0.8), U.S. biscuits category softness and retailer destocking, and increased 2026 growth investments (working media and supply-chain program); a Q4 top-line step-up is implied with Christmas activation and pricing benefits .

What Went Well and What Went Wrong

What Went Well

  • Regional growth breadth despite cocoa: Europe (+10.6% reported), AMEA (+9.0%), and Emerging Markets (+9.9%) led revenue, with pricing driving organic growth (+8.0 pp pricing vs -4.6 pp volume/mix) .
  • Management execution on pricing and activation: “We delivered solid top-line growth despite the impact of record-high cocoa cost inflation, with the third quarter representing peak costs of the year” (CEO) .
  • Seasonal momentum and cost actions: CFO expects better Q4 top-line led by Europe’s Christmas activation; productivity and cost efficiencies also in place to mitigate pressure .

What Went Wrong

  • Margins compressed sharply: GAAP gross margin fell 580 bps (26.8% vs 32.6% PY) and GAAP operating margin fell 490 bps (7.6% vs 12.5% PY) on input cost inflation and mix; Adjusted OI margin declined 690 bps to 12.0% .
  • U.S. category softness and elasticity in Europe: CFO flagged U.S. biscuit volume decline (~-4%) and European chocolate elasticities of 0.7–0.8 vs prior 0.4–0.5 assumptions, weighing volumes and share in pockets (UK, Germany) .
  • Guidance cut: FY Organic Net Revenue down to 4%+ and Adjusted EPS decline widened to ~15% constant FX, reflecting weaker U.S. demand and higher elasticities in Europe .

Financial Results

Quarterly Progression and Sequential/YoY Comparisons

MetricQ1 2025Q2 2025Q3 2025
Revenue ($USD Billions)$9.313 $8.984 $9.744
Diluted EPS ($)$0.31 $0.49 $0.57
Adjusted EPS ($)$0.74 $0.73 $0.73
Gross Margin (%)26.1% 32.7% 26.8%
Operating Margin (%)7.3% 13.0% 7.6%
Adjusted OI Margin (%)14.8% 14.3% 12.0%
MetricQ3 2024Q3 2025
Revenue ($USD Billions)$9.204 $9.744
Diluted EPS ($)$0.63 $0.57
Adjusted EPS ($)$0.95 $0.73
Gross Margin (%)32.6% 26.8%
Operating Margin (%)12.5% 7.6%
Adjusted OI Margin (%)18.9% 12.0%

Actuals vs S&P Global Consensus (Q3 2025)

MetricConsensusActualSurprise
Primary EPS ($)0.709*0.73 +2.9% (Beat)
Revenue ($USD Billions)9.673*9.744 +0.7% (Beat)
EBITDA ($USD Billions)1.611*1.399*-13.2% (Miss)

Values retrieved from S&P Global.*

Segment Breakdown (Reported Revenue and Margin)

RegionQ3 2024 Revenue ($MM)Q3 2025 Revenue ($MM)YoY Reported GrowthAdjusted OI Margin Q3 2024Adjusted OI Margin Q3 2025
Latin America$1,204 $1,238 +2.8% 11.8% 12.2%
AMEA$1,851 $2,017 +9.0% 18.8% 12.3%
Europe$3,323 $3,674 +10.6% 22.9% 8.2%
North America$2,826 $2,815 -0.4% 21.0% 19.4%
Emerging Mkts$3,530 $3,881 +9.9%
Developed Mkts$5,674 $5,863 +3.3%

KPIs and Drivers

KPIQ3 2025Notes
Organic Net Revenue Growth (%)3.4% Pricing +8.0 pp offset by Vol/Mix -4.6 pp
Pricing Contribution (pp)+8.0 Broad-based price realization
Volume/Mix Contribution (pp)-4.6 Elevated elasticity, downsizing, heatwave effects
YTD Free Cash Flow ($MM)$1,236 Operating cash flow $2,117 YTD
Net Debt ($MM)$19,955 Total Debt $21,322; Cash $1,367
Capital Returns (9M) ($B)$3.7 Dividends + buybacks

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Organic Net Revenue GrowthFY 2025~5% 4%+ Lowered
Adjusted EPS (constant FX)FY 2025~-10% YoY ~-15% YoY Lowered
Free Cash FlowFY 2025$3B+ $3B+ Maintained
Currency impactFY 2025~0% to revenue/EPS +0.5% revenue, +$0.05 EPS Raised (tailwind)

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2 2025)Current Period (Q3 2025)Trend
Cocoa inflation and pricingQ1: Strategy on RGM, protect key price points; pricing landed in Europe, elasticities ~0.5; anticipate small surplus and eventual price normalization . Q2: Cocoa fundamental outlook improving; took advantage of lower prices; butter ratios normalizing; 2026 cocoa seen deflationary; protect GP dollars .Q3 saw peak cocoa cost; margins compressed; moderation in cocoa noted; 2026 cocoa expected deflationary, targeting HSD EPS growth .Improving fundamentals; deflationary in 2026; reinvestment planned
Europe elasticities & pricingQ1: Europe pricing landed; elasticities aligned; strong Easter . Q2: Heatwave depressed volumes; elasticities monitored .Elasticities at 0.7–0.8 vs expected 0.4–0.5; specific price point resets (e.g., 300g tablets), seasonal activity to improve Q4 .Elasticities higher; mitigation actions underway
U.S. biscuits demand & destockingQ1: U.S. consumer anxiety; retailer destocking; focus on <$3 packs and multipacks . Q2: Category volume ~-3%; surgical pricing; alternate channel share gains; Q3 clean of destocking .Category volume down ~-4%; shift to value, club, online; multipacks and C-stores; protect key price points; expect gradual improvement with pricing and activation .Persistent softness; tactical pricing/pack and channel actions
Emerging marketsQ1: Solid growth China/Brazil; India softer; protect entry price points . Q2: EM growth engines; pricing landed; watch elasticities .EM chocolate elasticity ~0.3; Brazil double-digit growth; Mexico improving; China near-term pressure; overall positive .Healthy; volume/mix stabilizing
2026 investment cadence (working media, supply chain)Q2: Maintaining working media; reinvest if cocoa normalizes .2026 working media “big step up”; launch Biscoff platforms; multi-year North America supply chain program to automate bakeries and DSD logistics (benefits from 2027) .Investment rising; structural cost program initiated
Tariffs/macroQ1: USMCA compliance limits tariff impact; cautious macro stance . Q2: Tariffs minimal/manageable, hedged; currency hedges extended .Tariff/macro volatility cited; guidance reflects weaker U.S. demand and elasticities .Volatility manageable; embedded in outlook
Health/GLP-1Q2: No material GLP-1 impact; category weakness economic-driven .Reiterated no significant GLP-1 effect; protein bars growing (Perfect Bar, Builder’s) .Neutral; selective health segments growing

Management Commentary

  • CEO: “We delivered solid top-line growth despite the impact of record-high cocoa cost inflation, with the third quarter representing peak costs of the year… We remain confident… which position us well for next year and beyond.” .
  • CFO on FY guide change and Q4: “With incremental softening of the U.S. biscuit market… and higher chocolate elasticities in Europe… the implied Q4 shows a step up in the top line… and over-delivery of EBIT vs last year.” .
  • CEO on Europe elasticity and price points: “Overall… elasticity is around 0.7, 0.8… We passed two key price points on our 300-gram range in chocolate… we need to bring it back to the right price point.” .
  • CFO on 2026: “Cocoa will be deflationary in 2026… our goal is high single-digit EPS growth… even after material investments.” .
  • CFO on North America supply chain program: “Address mostly cost… automation… DSD logistics simplification… meaningful impact starting most likely as of 2027.” .

Q&A Highlights

  • Europe elasticities higher than modeled (0.7–0.8), with targeted price resets and seasonal activation to improve volumes; seasonal products carry lower elasticity .
  • U.S. strategy emphasizes channel expansion (club, dollar/value, e-commerce, C-stores), multipacks, and protecting key price points (~$3–$4) to balance value and profitability .
  • FY 2025 outlook implies Q4 top-line step-up driven by Europe seasonality and pricing; U.S. volume remains pressured but pricing aids top/bottom line .
  • 2026 spending to step up in working media; non-working media controlled; overhead actions and SG&A savings to level 2025 baseline (incentives normalized) .
  • GLP-1 impact remains immaterial; category weakness mainly economic; protein bar brands (Perfect Bar, Builder’s) growing 20%+ .

Estimates Context

  • EPS: Actual $0.73 vs consensus $0.709* — bold beat on EPS despite margin pressure, aided by lower taxes and fewer shares .
  • Revenue: Actual $9.744B vs consensus $9.673B* — slight beat on pricing-led growth .
  • EBITDA: Actual $1.399B* vs consensus $1.611B* — miss underscores cost inflation and mix headwinds.
    Values retrieved from S&P Global.*

Key Takeaways for Investors

  • Pricing resilience continues to support revenue, but elevated elasticities (Europe) and U.S. category softness cap volume; margin recovery likely depends on cocoa normalization and mix improvement .
  • Guidance reset reduces 2025 expectations; however, 2026 setup improves with deflationary cocoa view and reinvestment (working media, supply-chain automation), targeting high single-digit EPS growth .
  • Near term (Q4) catalyst: seasonal activation and incremental pricing should lift Europe’s volumes; monitor U.S. scanner trends, multipack growth, and channel share gains .
  • Watch margins: Adjusted OI margin down to 12.0% in Q3; EBITDA miss vs consensus highlights cost pressure — cocoa moderation plus productivity and reduced A&C/non-working media should help stabilize .
  • Balance sheet/cash returns remain supportive (YTD FCF $1.24B, $3.7B capital returned 9M); Net Debt at ~$20B — prudent buybacks likely tactical around valuation and outlook .
  • Strategic product angles: premium (Tate’s), health (protein bars), co-branded innovations (Cadbury Biscoff) to drive mix and share in 2026 amid reinvestment .
  • Risk checks: elasticity persistence, U.S. consumer sentiment, tariff/currency volatility; actions embedded in outlook and hedging strategy .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%